Ronald P. DeMatteo

Follow

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Nomograms in oncology: more than meets the eye	2015	Vinod P. Balachandran Mithat Gönen J. Joshua Smith Ronald P. DeMatteo
+ PDF Chat	Evaluation of the Value of Attribution in the Interpretation of Adverse Event Data: A North Central Cancer Treatment Group and American College of Surgeons Oncology Group Investigation	2010	Shauna L. Hillman Sumithra J. Mandrekar Brian M. Bot Ronald P. DeMatteo Edith A. Perez Karla V. Ballman Heidi Nelson Jan C. Buckner Daniel J. Sargent
+	Questionable value of attribution when interpreting adverse event data: A joint evaluation by North Central Cancer Treatment Group (NCCTG) and American College of Surgeons Oncology Group (ACOSOG)	2007	Shauna L. Hillman Daniel J. Sargent Brian M. Bot Ronald P. DeMatteo Edith A. Perez Karla V. Ballman Sumithra J. Mandrekar

Common Coauthors

Coauthor	Papers Together
Shauna L. Hillman	2
Brian M. Bot	2
Edith A. Perez	2
Karla V. Ballman	2
Sumithra J. Mandrekar	2
Daniel J. Sargent	2
Heidi Nelson	1
Jan C. Buckner	1
Mithat Gönen	1
Vinod P. Balachandran	1
J. Joshua Smith	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis	2003	Sunil J Rao	1
+ PDF Chat	Between-Method Differences in Prostate-Specific Antigen Assays Affect Prostate Cancer Risk Prediction by Nomograms	2011	Carsten Stephan Kerstin Siemßen Henning Cammann Frank Friedersdorff Serdar Değer Mark Schrader Kurt Miller Michael Lein Klaus Jung Hellmuth‐Alexander Meyer	1
+ PDF Chat	Concordance probability and discriminatory power in proportional hazards regression	2005	Mithat Gönen Glenn Heller	1
+ PDF Chat	Decision Curve Analysis: A Novel Method for Evaluating Prediction Models	2006	Andrew J. Vickers Elena B. Elkin	1
+	How To Build and Interpret a Nomogram for Cancer Prognosis	2008	Alexia Iasonos Deborah Schrag Ganesh V. Raj Katherine S. Panageas	1
+ PDF Chat	Dealing With a Deluge of Data: An Assessment of Adverse Event Data on North Central Cancer Treatment Group Trials	2005	Michelle R. Mahoney Daniel J. Sargent Michael J. O’Connell Richard M. Goldberg Paul Schaefer Jan C. Buckner	1
+	Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer	2001	Michael W. Kattan Louis Potters John C. Blasko David Beyer Paul Fearn William Cavanagh Steve Leibel Peter T. Scardino	1
+ PDF Chat	Nomogram to Predict Cycle-One Serious Drug-Related Toxicity in Phase I Oncology Trials	2014	David M. Hyman Anne Eaton Mrinal M. Gounder G. Smith Erika G. Pamer Martee L. Hensley David R. Spriggs Percy Ivy Alexia Iasonos	1
+	Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer	2003	Michael W. Kattan	1
+	Factors Affecting Workload of Cancer Clinical Trials: Results of a Multicenter Study of the National Cancer Institute of Canada Clinical Trials Group	2002	Kathyrn Roche Nancy Paul Bobbi Smuck Marlo Whitehead Benny Zee Joseph L. Pater Mary-Anne Hiatt Hugh Walker	1